Regulation of Lipid Droplet Biogenesis and Lipophagy
脂滴生物发生和脂肪自噬的调控
基本信息
- 批准号:10375405
- 负责人:
- 金额:$ 33.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:ActinsAddressAtherosclerosisBindingBiochemicalBiogenesisCapsid ProteinsCatabolismCellsCholesterol EstersComplexConsumptionCoupledCytoskeletonDataDietary Fatty AcidDiseaseDockingEnergy SupplyExerciseFailureFatty acid glycerol estersFutureGTP BindingGoalsGrowthGuanine NucleotidesGuanosine Triphosphate PhosphohydrolasesHealthcareHomeostasisIndividualInsulin ResistanceIntakeLeadLipidsLipodystrophyMediatingMembraneMetabolicMetabolic DiseasesMetabolic syndromeMetabolismMeteorMolecularMutationNonesterified Fatty AcidsNucleotidesObesityOrganellesOrganismPathogenesisPlayProcessPropertyProteinsPublic HealthRegulationResearchRoleStarvationSurfaceSystemTriglyceridesUnited Statesarmconstrictiondietarydietary excessinsightlipid metabolismmechanical forcenon-alcoholic fatty liver diseasenoveloverexpressionreconstitutionrecruitresponsestructural biology
项目摘要
ABSTRACT
Metabolic diseases are a pressing public health issue in the United States. With the meteoric rise of insulin
resistance, obesity, and atherosclerosis, mechanistic understanding of lipid metabolism could not be more
imperative. Many of these metabolic disorders involve improper storage of lipids into cellular lipid storage
organelles known as lipid droplets (LDs). These unique organelles, which contain a core of triacylglycerols and
cholesterol esters, accumulate when dietary free fatty acids are abundant, and conversely get consumed when
there is a high demand for energy. In this way, LDs are essential for both cellular and whole-body
homeostasis. Proteins that reside on the surface of LDs play critical roles in the dynamic turnover of LDs by
controlling the intake and release of the lipids stored within. Although the metabolic roles of LDs are well
known, the mechanisms employed to regulate the growth and catabolism of individual LDs are poorly
understood. We have identified two proteins, DFCP1 and WHAMM, which are poised to function as crucial
metabolic switches for LDs. In particular, we found that DFCP1 localizes to compartments that are involved in
both LD biogenesis and catabolism. Moreover, we discovered that DFCP1 has unique biochemical properties
that allow it to form an oligomeric coat on LDs, which suggests that it could play a role in the tethering of LDs to
the ER and other LDs. Forcing DFCP1 to disassemble from LDs leads to misregulated LD catabolism. Thus,
we postulate that DFCP1 functions as a molecular switch that releases growing LDs from the ER for
catabolism. Interestingly, LD release is coupled to the accumulation of the activator of the Arp2/3 complex,
WHAMM, and actin. We found that accumulation of WHAMM and actin to LDs occurs specifically in response
to starvation, where it drives actin-mediated mobilization and constriction of LDs. Consequently, the goals of
this proposal are to define the molecular mechanisms employed by DFCP1, WHAMM, and the actin
cytoskeleton to drive LD catabolism. To fully address these questions, we will use a bottom-up approach to
determine the mechanism and molecular properties that allow DFCP1 to switch LDs from growth to catabolism
(Aim 1). In parallel, we will examine how WHAMM and the Arp2/3 complex coordinate with DFCP1 to drive LD
dynamics and catabolism (Aim 2). The mechanistic insight obtained by these studies will provide new insights
into how LD metabolism helps to maintain cellular homeostasis, but also how misregulation of this process
contributes to the pathogenesis of metabolic diseases.
摘要
代谢性疾病是美国一个紧迫的公共卫生问题。随着胰岛素的迅速崛起
抵抗,肥胖和动脉粥样硬化,对脂质代谢的机制理解不能再多了
势在必行这些代谢紊乱中的许多涉及脂质不适当地储存到细胞脂质储存中
称为脂滴(LDs)的细胞器。这些独特的细胞器,其中包含一个核心的三酰基甘油和
胆固醇酯,积累时,膳食中的游离脂肪酸是丰富的,相反,得到消耗时,
对能源的需求很高。因此,LD对细胞和全身都是必不可少的。
体内平衡存在于LD表面的蛋白质在LD的动态周转中起关键作用,
控制储存在其中的脂质的摄入和释放。虽然LD的代谢作用很好,
已知,用于调节单个LD的生长和代谢的机制很差
明白我们已经确定了两种蛋白质,DFCP 1和WHAMM,它们将作为关键的功能发挥作用。
LD的代谢开关特别是,我们发现DFCP 1定位于参与细胞凋亡的区室。
LD生物成因和catalysts。此外,我们发现DFCP 1具有独特的生化特性,
这使得它能够在LD上形成低聚物涂层,这表明它可能在LD的束缚中发挥作用,
和其他LD。迫使DFCP 1从LD上拆卸导致LD催化剂失调。因此,在本发明中,
我们假设DFCP 1作为一个分子开关,从ER释放生长中的LD,
猫有趣的是,LD释放与Arp 2/3复合物的激活剂的积累相关联,
WHAMM和肌动蛋白。我们发现WHAMM和肌动蛋白对LDs的积累特异性地发生在
饥饿,在那里它驱动肌动蛋白介导的动员和LD的收缩。因此,
这一建议是为了确定DFCP 1,WHAMM和肌动蛋白的分子机制,
细胞骨架来驱动LD催化剂。为了充分解决这些问题,我们将采用自下而上的方法,
确定允许DFCP 1将LD从生长转换为催化的机制和分子特性
(Aim 1)。同时,我们将研究WHAMM和Arp 2/3复合体如何与DFCP 1协调以驱动LD
动力学和催化剂(目标2)。这些研究所获得的机理见解将提供新的见解
LD代谢如何帮助维持细胞内稳态,以及如何错误调节这一过程,
有助于代谢疾病的发病机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID J KAST其他文献
DAVID J KAST的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID J KAST', 18)}}的其他基金
Regulation of Lipid Droplet Biogenesis and Lipophagy
脂滴生物发生和脂肪自噬的调控
- 批准号:
10797475 - 财政年份:2020
- 资助金额:
$ 33.08万 - 项目类别:
Regulation of Lipid Droplet Biogenesis and Lipophagy
脂滴生物发生和脂肪自噬的调控
- 批准号:
10585916 - 财政年份:2020
- 资助金额:
$ 33.08万 - 项目类别:
Regulation of Lipid Droplet Biogenesis and Lipophagy
脂滴生物发生和脂肪自噬的调控
- 批准号:
10133099 - 财政年份:2020
- 资助金额:
$ 33.08万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 33.08万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 33.08万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 33.08万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 33.08万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 33.08万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 33.08万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 33.08万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 33.08万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 33.08万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 33.08万 - 项目类别:
Research Grant














{{item.name}}会员




